Business StandardCenter·
Mounjaro sales soar 502% as India's GLP-1 drug market expands rapidly
Mounjaro has overtaken other GLP-1 medicines to become India's top-selling brand, as demand for newer diabetes and weight-loss treatments rises
Read at Business Standard →



